Open-label Study to Investigate the Safety, PK, and Pharmacodynamics of GSK1120212 in Subjects With Solid Tumors or Lymphoma
Clinical trial NCT00687622 · COMPLETED
Trial details
- NCT number
- NCT00687622
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-28
- Primary completion
- 2011-06-07
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.